Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.
Blood Cancer Discov. 2023 Mar 1;4(2):118-133. doi: 10.1158/2643-3230.BCD-22-0074.
Blood Cancer Discov. 2023.
PMID: 36413381
Free PMC article.
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma.
Hasanali ZS, Razzo B, Susanibar-Adaniya SP, Garfall AL, Stadtmauer EA, Cohen AD.
Hasanali ZS, et al.
Hematol Oncol Clin North Am. 2024 Apr;38(2):383-406. doi: 10.1016/j.hoc.2023.12.004. Epub 2023 Dec 28.
Hematol Oncol Clin North Am. 2024.
PMID: 38158242
Free PMC article.
Review.
Item in Clipboard
High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma.
Shan X, Long Q, Garfall AL, Susanibar-Adaniya SP.
Shan X, et al.
Blood Cancer J. 2023 May 22;13(1):86. doi: 10.1038/s41408-023-00855-1.
Blood Cancer J. 2023.
PMID: 37217520
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite